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Abstract
BACKGROUND
Hepatic sinusoidal obstruction syndrome (SOS) is caused by damage to hepatic
sinusoidal endothelial cells that results in fibrous obliteration of intrahepatic
venules and necrosis of hepatocytes. Currently the diagnosis is primarily based
on nonspecific clinical features and invasive liver biopsy. Therefore, noninvasive
imaging methods are required for the early diagnosis and severity assessment of
hepatic SOS.
AIM
To determine the effectiveness of supersonic shear wave imaging (SSI) and dual
energy computed tomography (DECT) for diagnosing hepatic SOS using a rabbit
model.
METHODS
Among nine New Zealand white rabbits (3-4 kg, male), three in control group
ingested normal saline for 20 d and six in the SOS group ingested 6-thioguanine
(5 mg/kg/d) for 20 d. Liver stiffness was measured using SSI on days 0, 3, 10,
and 20. On the same days, liver perfusion was evaluated from virtual
monochromatic images of 55 keV and iodine map using DECT. Morphologic
changes in the liver were assessed using CT. Final pathology scores were
compared between the two groups. Liver stiffness and perfusion parameters
were compared according to the groups, days, and pathology scores.
RESULTS
Final pathology scores were significantly higher in the SOS than the control
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group (median 22 vs 2, P = 0.024). No gross morphologic changes were seen in
livers. Liver stiffness, Hounsfield Unit values, and iodine concentrations were
higher in the SOS compared to the control group on days 10 and 20 (all, P ≤
0.007). Compared to day 0, liver stiffness and perfusion parameters were higher
on day 20 in the SOS group (all, P ≤ 0.001). Correlation coefficients for liver
stiffness (r = 0.635), Hounsfield Unit values (r = 0.587), and iodine concentration
(r = 0.611) with final pathology scores were positive without significance (all, P >
0.05).
CONCLUSION
Liver stiffness and perfusion parameters were significantly increased in the livers
of a rabbit SOS model. SSI and DECT might aid in early diagnosis of hepatic SOS.
Key words: Hepatic sinusoidal obstruction syndrome; Elasticity imaging techniques;
Iodine; Computed tomography; Liver; Animals
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: Noninvasive imaging methods are required for the early diagnosis and severity
assessment of hepatic sinusoidal obstruction syndrome (SOS). This study showed that
liver stiffness on supersonic shear wave imaging was significantly elevated as hepatic
SOS progressed in rabbit model. In addition, as hepatic SOS progressed, perfusion
parameters measured on dual energy computed tomography were significantly elevated.
We suggested that quantitative imaging with supersonic shear wave imaging and dual
energy computed tomography could aid in the early diagnosis of hepatic SOS.
Citation: Shin J, Yoon H, Cha YJ, Han K, Lee MJ, Kim MJ, Shin HJ. Liver stiffness and
perfusion changes for hepatic sinusoidal obstruction syndrome in rabbit model. World J
Gastroenterol 2020; 26(7): 706-716
URL: https://www.wjgnet.com/1007-9327/full/v26/i7/706.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i7.706
INTRODUCTION
Hepatic sinusoidal obstruction syndrome (SOS) is a well-known serious complication
of  hematopoietic  stem cell  transplantation (HSCT)  and is  associated with drugs
including oxaliplatin-based chemotherapy[1-4]. Hepatic SOS, also known as hepatic
veno-occlusive disease, is caused by damage to hepatic sinusoidal endothelial cells
that results in fibrous obliteration of intrahepatic venules and necrosis of centrilobular
hepatocytes[3,5]. In pediatric patients, SOS is the most common cause of death after
graft-versus-host  reaction and infection in  patients  with HSCT with nonspecific
symptoms of painful hepatomegaly, fluid retention, and hyperbilirubinemia[3,6]. Liver
biopsy is the gold standard for the diagnosis of hepatic SOS, but is limited because of
its  invasiveness,  interobserver  variation,  and  sampling  error.  Even  though
conventional  computed  tomography  (CT)  or  ultrasonography  (US)  have
demonstrated  that  gross  changes  in  hepatic  SOS,  such  as  heterogeneous
hypoattenuation and patchy parenchymal enhancement with narrowing of hepatic
veins, those imaging findings are nonspecific and present after disease progression
while  diagnosing  hepatic  SOS  in  clinical  setting[7].  Therefore,  new  noninvasive
imaging biomarker for early diagnosis and severity assessment of hepatic SOS are
required as alternatives to liver biopsy and conventional imaging modalities[8].
US elastography is a noninvasive tool for evaluating liver stiffness. In addition to
transient elastography (TE) validated for assessment of liver fibrosis[9,10], shear wave
elastography (SWE) uses ultrasound waves to quantify the tissue-specific propagation
speed of  shear waves for  guidance of  grayscale US images[11,12].  SWE gives more
reliable  results  than  TE[13].  Supersonic  shear  wave  imaging  (SSI)  is  a  recently
introduced SWE technique characterized by ultrafast image acquisition using multiple
push beams and a color map with a wide range. SSI enables real-time analysis with
color display, a large field of view and multiple regions of interest, for advantages
over  acoustic  radiation  force  impulse  (ARFI).  Although  a  few  studies  reported
elevated liver stiffness using TE and ARFI in a rat or human SOS[14-18] and patients
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undergoing HSCT[19,20], no study has evaluated liver stiffness in hepatic SOS using SSI.
Dual energy CT (DECT) uses photon spectra generated by two distinctive tube
voltages to obtain additional information about tissue composition based on spectral
properties[21].  With material-specific  information,  virtual  monochromatic  images
(VMIs) and concentration map images of materials such as iodine and calcium can be
generated by DECT for quantitative diagnosis of liver steatosis and fibrosis[22-24]. In
hepatic  SOS,  toxic  injury  to  sinusoidal  endothelial  cells  might  cause  loss  of
autoregulation and reduction of blood flow in the sinusoids[1]. We postulated that
these events could result in different iodine concentrations in livers with SOS, but
little has been published on DECT imaging in hepatic SOS. Therefore, the purpose of
this study was to know liver stiffness and perfusion changes using SSI and DECT for
diagnosis of hepatic SOS using a rabbit model.
MATERIALS AND METHODS
Animal model
This study was approved by our institution’s Animal Experimental Committee and
performed according to local animal care guidelines. Nine male New Zealand white
rabbits weighting 3-4 kg were used. Three rabbits ingested normal saline via a 1 cc
syringe for 20 d and were the control group. Six rabbits ingested 6-thioguanine (6-TG,
5 mg/kg/d, four days in a week) for 20 d according to a previous study[25] and were
the  SOS group.  Rabbits  received standard diets  during  the  experiments.  Rabbit
conditions were monitored by radiologists and a veterinarian.
Laboratory studies
On days 0, 3, 10, and 20 during medication, laboratory and imaging examinations
were  performed  under  sedation.  Sedation  was  accomplished  by  intramuscular
injection of xylazine hydrochloride (1 mg/kg, Rompun; Bayer Korea, Seoul, South
Korea)  and  intravenous  injection  of  alfaxalone  (3  mg/kg,  Alfaxan®;  Careside,
Gyeonggi-do,  South  Korea)  with  the  help  of  a  veterinarian  before  starting
examinations.
Laboratory tests  were performed with samples from ear  veins.  Tests  were for
serum  aspartate  aminotransferase  (AST),  alanine  aminotransferase  (ALT),  total
bilirubin (Tbil), and direct bilirubin (Dbil) levels.
Imaging studies
For imaging studies, SWE and DECT were performed on days 0, 3, 10, and 20. Rabbits
were in a supine position on the scan table,  with forelegs up and tightened with
bandages. The upper abdomen was shaved for contact with the US probe. For SWE,
SSI (Aixplorer, SuperSonic Imagine, Aix-en-Provence, France; software version of 9.2)
was used with a 10-2 MHz linear transducer. An experienced pediatric radiologist
performed examinations. Liver stiffness was measured for the liver parenchyma at an
epigastric area because in rabbits, the liver left lobe was large and had fewer artifacts
from bowel loops than other lobes. Color maps were made for the liver parenchyma
avoiding  hepatic  vessels  and  bile  ducts.  A  round  region  of  interest  (ROI)  with
diameter 2-4 mm and depth of  about 1.5  cm was put on color maps when maps
appeared homogeneous during regular free breathing without intubation. Mean value
for liver stiffness within the ROI was automatically recorded in kPa units based on
Young’s modulus. Measurements were repeated seven times as in a previous study[26]
and mean values were recorded (Figure 1A). All processes were repeated twice and
two representative values were used for each rabbit.
CT was performed using DECT with fast kVp switching (80/140 kVp) on a single-
source dual-energy 64-channel multidetector CT scanner (GE Discovery CT750 HD
scanner, GE Healthcare, Milwaukee, Wisconsin, United States) on the same days.
Contrast  agent  iobitridol  (Xenetics  300,  Guerbet,  Roissy,  France)  at  2  cc/kg was
manually injected into an auricular vein, using the same institutional protocol as for
neonates. Scanning parameters were: Helical mode, rapid kVp switching between 80
and  140  kVp,  tube  current  260  mA,  detector  collimation  64  mm  ×  0.625  mm,
acquisition mode in axial plane, slice thickness 2.5 mm, pitch 1.375:1, soft convolution
kernel, and CT dose index volume 6.48 mGy. Single-phase portal venous phase was
acquired at fixed time delay 40 s following contrast material injection according to the
institutional CT scan protocol for neonates. Livers were scanned in the craniocaudal
direction.
Morphologic liver changes during the study period were assessed using CT. A
pediatric radiologist assessed the presence of liver parenchymal as heterogeneous
patchy enhancement, gallbladder (GB) wall edema, narrowed or invisible hepatic
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Figure 1
Figure 1  Representative images from supersonic shear wave imaging and dual energy computed tomography of rabbits in a sinusoidal obstruction
syndrome group on day 20. A: Mean liver stiffness value for livers in the sinusoidal obstruction syndrome group was 7.4 kPa; B: Iodine concentration in livers of the
sinusoidal obstruction syndrome group was 31.19 mg/mL.
veins,  hepatomegaly  showing  inferior  liver  margin  below  the  right  kidney,  or
presence of ascites using DECT images according to previous studies[7,27,28].
For quantitative assessments,  filtered back projection images without iterative
reconstruction were used for reconstruction and analysis. VMIs at 55 keV were used
for analysis because 70 or 80 kVp images were routinely used for neonate abdominal
CT in our hospital. Material density iodine maps were reconstructed. Round ROIs
were drawn in liver parenchyma avoiding hepatic vessels using an AW server (GE
Healthcare, Milwaukee, Wisconsin, United States; software version 2.0). ROIs were
positioned in the same place in the liver parenchyma on VMI 55 keV image and
iodine map (Figure 1B). Mean CT attenuations in Hounsfield units (HUs) and iodine
concentrations (mg/mL) within ROIs were recorded. ROIs were drawn three times
over liver parenchyma and three values were acquired for each parameter.
Radiation dose using mean effective dose by multiplying dose-length product with
k (conversion factor, 0.049 used for pediatric patients younger than one year old) of all
rabbits were assessed.
Pathologic scoring of hepatic SOS
On day 21, rabbits were sacrificed and hepatic specimens were obtained. Specimens
were fixed in 10% phosphate-buffered formalin (pH 7.1) for 24 h and put in 70%
ethanol. After obtaining paraffin blocks, hematoxylin and eosin, Masson’s trichrome,
and Verhoeffe-Van Gieson staining was performed. Final pathology scores for SOS
were assessed by an experienced board-certificated pathologist according to a scoring
system used previously[25]. Scores were assessed as the sum of each subscore in three
categories: sinusoidal, central vein, and necro-inflammatory damage. For evaluating
sinusoidal  damage,  sinusoidal  dilatation,  or  congestion  were  evaluated  using
subscores from 0 to 3. For evaluation of central vein damage, fraying of endothelial
cells  and  sludge  in  central  veins  were  assessed.  For  the  evaluation  of  necro-
inflammatory damage, apoptotic bodies, inflammatory cell infiltrates, steatosis, and
necrosis were scored separately. All scores were evaluated for 10 areas in lower power
fields; the possible range of scores 0 to 240. The pathologist was blind to the final
diagnosis of the rabbits.
Statistical analysis
Statistical  analysis was done with SAS (version 9.4,  SAS Institute Inc.,  Cary, NC,
United  States).  Final  pathology  scores  between  control  and  SOS  groups  were
compared using Mann-Whitney U tests. Differences in changing pattern of laboratory
results and quantitative imaging parameters including liver stiffness on SSI,  HU
values on VMI 55 keV images, and iodine concentration (mg/mL) on iodine maps
were assessed using linear mixed models. Values were compared between groups for
each day and compared between days 0 and 20 for each group in post hoc analysis.
Spearman’s correlation tests were used to determine correlations between results
measured  on  day  20  and  final  pathology  scores.  P  values  less  than  0.05  were
considered statistically significant.
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RESULTS
During the study period, three of six rabbits in the SOS group died unexpectedly on
days 10, 11, and 17. Results for these rabbits until the day of unexpected death were
used as much as possible. Pathology results were obtained on the day of death for
these rabbits, except the rabbit that died on day 17. The remaining three rabbits in the
SOS group all had examinations on days 0, 3, 10, and 20 and pathology results on day
21. Therefore, days 0 and 3 had results from all six rabbits, while day 10 had results
from 5 rabbits, and day 20 had results from 3 rabbits in the SOS group. The three
rabbits in the control group were alive through day 20.
Final pathology scores were significantly higher in the SOS group (n = 5, range 20-
42,  median 22)  than the  control  group (n  =  3,  range 2-11,  median 2)  (P  =  0.024).
According to the categories, the sum of scores for sinusoidal damage was 121 in the
SOS group and 15 in the control group. For central vein damage, the score was 3 for
the SOS group and 0 for the control group. For necro-inflammatory damage, the score
was 9 for the SOS group and 0 for the control  group. Liver parenchymal patchy
heterogeneous enhancement, GB wall edema, narrowed or invisible hepatic veins,
hepatomegaly, or ascites were not presented in CT images for both SOS and control
groups during the study period. The mean effective dose of DECT was 7.9 ± 1.6 mSv
for all rabbits.
Using linear mixed models, we saw significant differences in changing patterns of
liver stiffness,  HU values in VMI 55 keV, and iodine concentration between two
groups (all, P < 0.001) (Figure 2). Laboratory results showed no significant differences
between the two groups in patterns over 20 d. Post hoc analyses of laboratory and
imaging studies are in Table 1 and 2. Compared to controls, on day 20, AST, ALT, and
D.bil  values  were  significantly  higher  in  the  SOS group (P  =  0.004,  0.008,  0.013,
respectively) (Table 1). Liver stiffness values were significantly higher in the SOS
group on day 10 (9.48 kPa vs 4.02 kPa, P < 0.001) and day 20 (7.71 kPa vs 4.67 kPa, P =
0.007) compared to the control group (Table 2).  HU values for VMI 55 keV were
significantly higher in the SOS group on day 3 (167.68 HU vs 147.18 HU, P = 0.045),
day 10 (185.42 HU vs 129.05 HU, P < 0.001) and day 20 (179.81 HU vs 148.95 HU, P =
0.006). Iodine concentrations were significantly higher in the SOS group on day 3
(26.74 mg/mL vs 20.72 mg/mL, P = 0.022), day 10 (31.86 mg/mL vs 19.16 mg/mL, P <
0.001), and day 20 (35.14 mg/mL vs 23.85 mg/mL, P < 0.001).
When comparing laboratory results, AST, ALT, and Dbil values were significantly
higher  on  day  20  than  on  day  0  in  the  SOS  group  (P  =  0.001,  0.001,  and  0.004,
respectively), while there were no significant differences between days 0 and 20 in the
control group (Table 3). In quantitative imaging studies (Table 4), liver stiffness values
were significantly higher on day 20 than on day 0 in the SOS group (7.71 kPa vs 3.89
kPa, P < 0.001), but there was no significant difference of stiffness between day 0 and
day 20 in the control group (4.67 kPa vs 4.35 kPa, P = 0.752) (Table 4). HU values for
VMI 55 keV were significantly higher on day 20 in the SOS group (179.81 HU vs
158.77 HU, P = 0.001), with no differences in the control group (147.95 HU vs 153.18
HU, P = 0.510). Iodine concentrations were also significantly higher on day 20 in the
SOS group (35.14 mg/mL vs  24.2  mg/mL, P  <  0.001),  with no differences in the
control group (23.85 mg/mL vs 24.8 mg/mL, P = 0.539).
In assessing correlations among final pathology scores and laboratory results (Table
5), correlation coefficients were 0.323 for AST, 0.491 for ALT, 0.156 for Tbil, and 0.261
for Dbil, without statistical significance (P  > 0.05). In imaging studies, correlation
coefficients were 0.635 for liver stiffness, 0.587 for VMI 55 keV, and 0.611 for iodine
concentration, even without statistical significance (P > 0.05).
DISCUSSION
In  our  animal  study,  hepatic  SOS  was  induced  in  a  rabbit  model  by  orally
administered 6-TG. As described by Oancea et al[25], orally administered 6-TG causes
hepatic  SOS  in  a  dose-dependent  manner  in  a  murine  model  and  our  findings
confirmed early  and acute  sinusoidal  injury  in  rabbit  model  by  pathology.  Our
pathology results showed early and acute changes in the SOS group, which was
different from the control group. Because rabbits in the SOS group did not show
morphologic changes on CT images, these results confirmed the early disease stages
of our rabbit model. In this model, non-invasive SSI and DECT examinations had
promising results for diagnosing hepatic SOS. Our study was meaningful because
changes in quantitative imaging studies with SSI and DECT occurred earlier than
morphologic changes in conventional CT.
Our SSI results indicated that hepatic SOS led to elevated liver stiffness. Significant
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Table 1  Comparison of laboratory results between control and sinusoidal obstruction syndrome groups
Results Days Control group SOS group Differences P value
AST (IU/L) 0 32.67 (-55.57, 120.9) 20.5 (-41.89, 82.89) 12.17 (-95.9, 120.23) 0.818
3 24.67 (-63.57, 112.9) 23 (-39.39, 85.39) 1.67 (-106.4, 109.73) 0.975
10 20.67 (-67.57, 108.9) 26.4 (-42.5, 95.3) -5.73 (-117.68, 106.22) 0.917
20 26.33 (-61.9, 114.57) 221.34 (130.35, 312.33) -195.01 (-321.75, -68.26) 0.004b
ALT (IU/L) 0 38 (3.97, 72.03) 33.17 (9.11, 57.23) 4.83 (-36.84, 46.51) 0.813
3 44.67 (10.64, 78.69) 41.83 (17.77, 65.89) 2.83 (-38.84, 44.51) 0.890
10 33.67 (-0.36, 67.69) 25.41 (-1.18, 51.99) 8.26 (-34.92, 51.44) 0.697
20 40.67 (6.64, 74.69) 109.35 (74.12, 144.58) -68.69 (-117.67, -19.71) 0.008b
Tbil (mg/dL) 0 0.27 (-0.18, 0.72) 0.42 (0.1, 0.73) -0.15 (-0.7, 0.4) 0.579
3 0.63 (0.18, 1.08) 0.52 (0.2, 0.83) 0.12 (-0.43, 0.67) 0.666
10 0.9 (0.45, 1.35) 1.18 (0.82, 1.53) -0.28 (-0.85, 0.29) 0.328
20 0.53 (0.08, 0.98) 0.96 (0.49, 1.43) -0.43 (-1.07, 0.22) 0.186
Dbil (mg/dL) 0 0.1 (-0.08, 0.28) 0.12 (-0.01, 0.25) -0.02 (-0.24, 0.21) 0.879
3 0.13 (-0.05, 0.32) 0.17 (0.04, 0.3) -0.03 (-0.26, 0.19) 0.760
10 0.17 (-0.02, 0.35) 0.26 (0.12, 0.4) -0.09 (-0.32, 0.14) 0.411
20 0.13 (-0.05, 0.32) 0.47 (0.28, 0.65) -0.33 (-0.59, -0.08) 0.013a
Values are estimated mean and 95% confidence interval.
aP < 0.05.
bP < 0.01. SOS: Sinusoidal obstruction syndrome; AST: Serum aspartate aminotransferase; ALT: Alanine aminotransferase; Tbil: Total bilirubin; Dbil: Direct
bilirubin.
stiffness changes measured by SSI were observed starting on day 10, with no obvious
morphologic change even with contrast enhanced CT throughout the test days. To the
best of our knowledge, this is the first study to investigate the effectiveness of SSI for
assessing hepatic SOS. SSI has benefits such as a large area to measure,  ultrafast
imaging, and low failure rate compared with TE or ARFI[29]. Previous studies with TE
or ARFI reported an increased liver stiffness in a rat model[14] and in pediatric or adult
patients  following  HSCT[15-18,30].  A  study  demonstrated  that  SWE detects  earlier
changes than color Doppler study in SOS[20]. Increased liver stiffness could be from
hepatic  venous  congestion  in  the  SOS  model,  although  liver  inflammation  and
cholestasis could also affect increased liver stiffness[31]. Our study confirmed that SSI
could be a method for monitoring disease progression or treatment response to SOS.
The SSI values were highest on day 10 and decreased on day 20. Attention is required
to interpret decreased SSI value on day 20 because of the relatively small number of
animals at day 20. Further clinical research is required to prove the potential utility of
SSI in the detection and follow up of hepatic SOS.
Previous studies with conventional CT reported nonspecific morphologic changes
such as hepatomegaly, ascites,  heterogeneous patchy parenchymal enhancement,
narrowed hepatic veins, and GB wall edema for diagnosis of hepatic SOS; these might
lack sensitive detection for early changes in hepatic SOS[28,32]. Our study demonstrated
that quantitative DECT showed increased HU values on VMI 55 keV and increased
iodine concentrations in material density maps in the liver parenchyma before gross
morphologic changes occurred. These quantitative values also showed increasing
trends throughout the study period, which may be promising for follow-up of the
severity of hepatic SOS. Low-keV images using VMI could enhance iodine effects[33].
This method could aid in the detection of changing patterns of iodine accumulation in
the liver parenchyma in hepatic SOS using low-keV images and iodine maps.
Increased HU values and iodine concentrations in our study might be from iodine
congestion due to endothelial injury of sinusoids and small intrahepatic venules. A
previous study found that on pathology, hepatic SOS showed blood stagnation in
dilated sinusoids[32].  However,  heterogeneous  hypoattenuation and patchy liver
enhancement  were  observed  in  a  small  number  of  SOS  patients  following
neoadjuvant  chemotherapy  or  pyrrolizidine  alkaloid  ingestion[7,27,34,35].  These
heterogeneous  hypoattenuations  might  be  related  to  delayed  blood  inflow and
decreased flow velocity from damaged sinusoids filled with cell debris, red cells, and
extracellular matrix[34,35]. Different patterns of enhancement in hepatic SOS could be
from different stages and etiologies of SOS according to the studies. Delayed blood
flow and decreased flow velocity from hepatic SOS could represent an advanced stage
and this could be different from our study. Our study found iodine accumulation in
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Table 2  Comparison of quantitative imaging results between control and sinusoidal obstruction syndrome groups
Parameters Days Control group SOS group Differences P value
Liver stiffness (kPa) 0 4.35 (2.82, 5.88) 3.89 (2.81, 4.97) 0.46 (-1.41, 2.33) 0.623
3 5.68 (4.16, 7.21) 6.38 (5.3, 7.45) -0.69 (-2.56, 1.18) 0.458
10 4.02 (2.49, 5.54) 9.48 (8.29, 10.66) -5.46 (-7.39, -3.53) < 0.001b
20 4.67 (3.14, 6.19) 7.71 (6.17, 9.25) -3.04 (-5.21, -0.87) 0.007b
VMI 55 keV (HU) 0 153.18 (137.07, 169.29) 158.77 (147.38, 170.16) -5.59 (-25.33, 14.14) 0.550
3 147.18 (131.07, 163.29) 167.68 (155.92, 179.44) -20.5 (-40.44, -0.55) 0.045a
10 129.05 (112.94, 145.16) 185.42 (173.62, 197.22) -56.37 (-76.34, -36.4) < 0.001b
20 148.95 (132.83, 165.06) 179.81 (166.5, 193.11) -30.86 (-51.69, -10.03) 0.006b
Iodine concentration (mg/mL) 0 24.8 (20.76, 28.84) 24.2 (21.34, 27.05) 0.61 (-4.34, 5.55) 0.794
3 20.72 (16.69, 24.76) 26.73 (23.79, 29.67) -6.01 (-11, -1.02) 0.022a
10 19.16 (15.12, 23.19) 31.86 (28.91, 34.8) -12.7 (-17.7, -7.7) < 0.001b
20 23.85 (19.81, 27.88) 35.14 (31.84, 38.44) -11.29 (-16.49, -6.1) < 0.001b
Values are estimated mean and 95% confidence interval.
aP < 0.05.
bP < 0.01. SOS: Sinusoidal obstruction syndrome; VMI: Virtual monochromatic image; HU: Hounsfield unit.
the liver parenchyma in the acute stage of the SOS from blood stagnation. Endothelial
injuries and edema of sinusoids could occur in early stage SOS, while hepatic necrosis
and deposition of  collagen,  fibrous tissues  could occur  in  disease  progression[7].
Therefore,  different stages of SOS might have different enhancement patterns.  A
previous study suggested that the etiology of SOS could cause different enhancement
patterns because tumor-related factors also alter liver perfusion and steatosis could
affect liver attenuation after receiving chemotherapy[34]. Direct quantification of iodine
in  the  liver  parenchyma  with  DECT  may  be  a  possible  objective  method  for
overcoming the inherent ambiguous nature of attenuation in livers with SOS using
conventional CT[24,36]. Further studies for assessing DECT results according to stage
and etiology of SOS in patients are needed.
This  study  has  several  limitations.  First,  the  small  number  of  animals  and
unexpected death in SOS group in this experimental study was the main reason for
the lack of statistical significance in the correlation between final pathology scores and
laboratory results or imaging parameters, even though correlation coefficients were
about 0.6 for quantitative imaging results. Second, we did not assess hepatic arterial
resistance index or flow direction of the portal vein using Doppler US in rabbits.
Third, rabbits were assessed until day 20 and advanced disease stages with apparent
morphologic changes were not evaluated. However, because this study demonstrated
the potential effectiveness of SSI and DECT for hepatic SOS, further large studies with
patients and animal models are needed.
In conclusion, changes of quantitative parameters with SSI and DECT could aid the
diagnosis of hepatic SOS before morphologic changes were apparent in the liver of a
rabbit model. Liver stiffness on SSI, HU values on VMI with low keV, and iodine
concentrations on DECT were significantly  increased in  livers  according to  SOS
progression.
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Table 3  Comparison of laboratory results between days 0 and 20
Results Groups Day 0 Day 20 Difference P value
AST (IU/L) Control 32.67 (-55.57, 120.9) 26.33 (-61.9, 114.57) 6.33 (-118.48, 131.15) 0.916
SOS 20.5 (-41.89, 82.89) 221.34 (130.35, 312.33) -200.84 (-310.9, -90.78) 0.001b
ALT (IU/L) Control 38 (3.97, 72.03) 40.67 (6.64, 74.69) -2.67 (-51.54, 46.21) 0.910
SOS 33.17 (9.11, 57.23) 109.35 (74.12, 144.58) -76.19 (-119.14, -33.24) 0.001b
Tbil (mg/dL) Control 0.27 (-0.18, 0.72) 0.53 (0.08, 0.98) -0.27 (-0.9, 0.37) 0.387
SOS 0.42 (0.1, 0.73) 0.96 (0.49, 1.43) -0.54 (-1.1, 0.02) 0.057
Dbil (mg/dL) Control 0.1 (-0.08, 0.28) 0.13 (-0.05, 0.32) -0.03 (-0.29, 0.22) 0.792
SOS 0.12 (-0.01, 0.25) 0.47 (0.28, 0.65) -0.35 (-0.57, -0.13) 0.004b
Values are presented as estimated mean and 95% confidence interval.
bP < 0.01. SOS: sinusoidal obstruction syndrome; AST: Serum aspartate aminotransferase; ALT: Alanine aminotransferase; Tbil: Total bilirubin; Dbil: Direct
bilirubin.
Table 4  Comparison of quantitative imaging results between day 0 and 20
Parameters Groups Day 0 Day 20 Difference P value
Liver stiffness (kPa) Control 4.35 (2.82, 5.88) 4.67 (3.14, 6.19) -0.32 (-2.32, 1.69) 0.752
SOS 3.89 (2.81, 4.97) 7.71 (6.17, 9.25) -3.82 (-5.61, -2.02) < 0.001b
VMI 55 keV (HU) Control 153.18 (137.07, 169.29) 148.95 (132.83, 165.06) 4.23 (-8.48, 16.95) 0.510
SOS 158.77 (147.38, 170.16) 179.81 (166.5, 193.11) -21.04 (-32.7, -9.37) 0.001b
Iodine concentration (mg/mL) Control 24.8 (20.76, 28.84) 23.85 (19.81, 27.88) 0.95 (-2.12, 4.03) 0.539
SOS 24.2 (21.34, 27.05) 35.14 (31.84, 38.44) -10.94 (-13.77, -8.12) < 0.001b
Values are presented as estimated mean and 95% confidence interval.
bP < 0.01. SOS: Sinusoidal obstruction syndrome; VMI: Virtual monochromatic image; HU: Hounsfield unit.
Table 5  Assessment of correlation between final pathologic scores and laboratory results and quantitative imaging parameters
Results r (95%CI) P value
AST (IU/L) 0.323 (-0.511, 0.83) 0.453
ALT (IU/L) 0.491 (-0.358, 0.881) 0.230
Tbil (mg/dL) 0.156 (-0.623, 0.771) 0.726
Dbil (mg/dL) 0.261 (-0.557, 0.809) 0.551
Liver stiffness (kPa) 0.635 (-0.171, 0.919) 0.094
VMI 55 keV (HU) 0.587 (-0.241, 0.906) 0.133
Iodine concentration (mg/mL) 0.611 (-0.207, 0.913) 0.112
AST: Serum aspartate aminotransferase; ALT: Alanine aminotransferase; Tbil: Total bilirubin; Dbil: Direct bilirubin; VMI: Virtual monochromatic image;
HU: Hounsfield unit; CI: Confidence interval.
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Figure 2
Figure 2  Changing patterns of imaging results. A: Liver stiffness on supersonic shear wave imaging; B: Hounsfield unit values on virtual monochromatic image of
55 keV; C: Iodine concentration on iodine map of dual energy computed tomography on days 0, 3, 10, and 20 in control (blue) and sinusoidal obstruction syndrome
(SOS) (red) groups. All three quantitative values showed significant differences in changing pattern between control and SOS groups for all days (P < 0.001). aShows
significantly different results between control and SOS groups for each day.
ARTICLE HIGHLIGHTS
Research background
Hepatic  sinusoidal  obstruction  syndrome  (SOS)  is  a  well-known  serious  complication  of
hematopoietic stem cell  transplantation and is associated with chemotherapy. Noninvasive
imaging methods are required for the early diagnosis and severity assessment of hepatic SOS.
Research motivation
In pediatric patients, SOS is the most common cause of death in patients with hematopoietic
stem cell transplantation with nonspecific symptoms. Currently the diagnosis is primarily based
on nonspecific  clinical  features  and invasive liver  biopsy.  Therefore,  noninvasive imaging
methods are required for the early diagnosis and severity assessment of hepatic SOS. Supersonic
shear  wave  imaging  (SSI)  is  a  recently  introduced  US  elastography  technique  and  is  a
noninvasive tool for evaluating liver stiffness. Dual energy computed tomography (DECT) could
quantify tissue composition or iodine concentration. We postulated that these imaging studies
could quantify liver stiffness and perfusion changes in hepatic SOS.
Research objectives
The purpose of the study was to determine the effectiveness of SSI and DECT for diagnosing
hepatic SOS using a rabbit model.
Research methods
Among nine New Zealand white rabbits, three were in control group and six with 6-thioguanine
ingestion were in SOS group. Liver stiffness was measured using SSI and liver perfusion was
evaluated from virtual monochromatic images of 55 keV and iodine map using DECT on days 0,
3, 10, and 20. Liver stiffness and perfusion parameters were compared according to the groups,
days, and pathology scores.
Research results
Compared to the control group, final pathology scores were significantly higher in the SOS
group, while there were no gross morphologic changes using conventional  imaging.  Liver
stiffness, Hounsfield Unit values, and iodine concentrations were higher in the SOS compared to
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the control group as disease progression.
Research conclusions
This  study  showed  that  liver  stiffness  on  SSI  and  perfusion  parameters  on  DECT  were
significantly increased according to SOS progression in a rabbit  model.  We suggested that
quantitative imaging with SSI and DECT could aid in the early diagnosis of hepatic SOS.
Research perspectives
SSI  and DECT could  be  the  noninvasive  imaging studies  for  early  diagnosis  and severity
assessment of hepatic SOS. Because this study demonstrated the potential effectiveness of SSI
and DECT for hepatic SOS, further large studies with patients are needed.
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